ORGN 189 |
| Simon R. Cherry, Department of Biomedical Engineering, Department of Biomedical Engineering, University of California - Davis, One Shields Avenue, Davis, CA 95616 |
| Significant advances have been made over the past five years in developing new technologies designed for in vivo imaging of targeted and “smart” contrast agents. This presentation will summarize how these developments seek to take advantage of the advances in contrast agent chemistry, with a particular focus on high-sensitivity molecular imaging using optical and nuclear imaging approaches. Instrumentation for in vivo fluorescence and bioluminescence imaging will be discussed, with emphasis on new approaches to provide 3-D tomographic images with these modalities. High resolution positron emission tomography (PET) and single photon emission computed tomography (SPECT) will be introduced, and in vivo imaging based on these modalities discussed. The integration of multiple imaging modalities, that provide complementary information, also will be presented. |
|
Chemistry and Biological Applications of Imaging Agents and Molecular Beacons
1:25 PM-5:10 PM, Monday, March 29, 2004 Anaheim Convention Center -- Ballroom C, Oral
Division of Organic Chemistry |